Skip to main content

APROXIMACION MULTI-OMICA PARA LA CARACTERIZACION DE LA LEUCEMIA MIELOIDE AGUDA DE NOVO Y SECUNDARIA: ESTUDIO EN EL CONTEXTO DEL CONSORCIO NUCLEAR Y EL GRUPO ESPAÑOL DE SINDROMES MIELODISPLASICOS

PI20/01845

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INV. BIOSANITARIA EN ANDALUCIA ORIENTAL ALEJANDRO OTERO (FIBAO)
Execution centre ibs.GRANADA (INSTITUTO DE INVESTIGACION BIOSANITARIA DE GRANADA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia, a CRuCIAL study

  • García Martín, Paloma|||0000-0001-5582-8575
  • Moñiz Díez, Ana|||0000-0002-3260-9553
  • Sánchez Maldonado, José Manuel|||0000-0002-4651-3675
  • Cabrera Serrano, Antonio José|||0000-0003-0346-7960
  • ter Horst, Rob|||0000-0003-0576-5873
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Landi, Stefano|||0000-0001-8364-6357
  • Macauda, Angelica|||0000-0001-9820-5079
  • Clay-Gilmour, Alyssa|||0000-0001-9998-4879
  • Hernández-Mohedo, Francisca
  • Niazi, Yasmeen|||0000-0002-7560-2247
  • González-Sierra, Pedro Antonio|||0000-0002-6492-1728
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Rodriguez-Sevilla, Juan Jose|||0000-0002-4741-7925
  • Maffei, Rossana|||0000-0002-3518-2006
  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Giaccherini, Matteo|||0000-0002-0363-6632
  • Puiggros, Anna|||0000-0001-9627-4978
  • Cerhan, James|||0000-0002-7482-178X
  • Marasca, Roberto|||0000-0002-6431-6878
  • Cañadas-Garre, Marisa|||0000-0003-1103-5658
  • Lopez Nevot, Miguel Angel|||0000-0002-3465-6062
  • Chen-Liang, Tzu|||0000-0001-5969-8640
  • Thomsen, Hauke|||0000-0001-5951-3116
  • Gámez, Irene
  • Morros, Rosa|||0000-0001-6752-8748
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • García-Álvarez, María|||0000-0001-8864-1168
  • Llorca, Javier|||0000-0001-8569-861X
  • Jerez, Andrés|||0000-0002-2079-6638
  • Berndt, Sonja
  • Butrym, Aleksandra|||0000-0002-8199-2018
  • Norman, Aaron D.|||0000-0002-4208-2708
  • Casabonne, Delphine
  • Luppi, Mario|||0000-0002-0373-1154
  • Slager, Susan|||0000-0002-5173-4712
  • Hemminki, Kari|||0000-0002-2769-3316
  • Li, Yang
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Campa, Daniele|||0000-0003-3220-9944
  • Canzian, Federico|||0000-0002-4261-4583
  • De Sanjose, Silvia|||0000-0002-5909-676X
  • Försti, Asta|||0000-0002-9857-4728
  • Netea, Mihai G.|||0000-0003-2421-6052
  • Jurado, Manuel|||0000-0001-9156-3797
  • Sainz, Juan|||0000-0002-9355-2423
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

  • Cabrera Serrano, Antonio José|||0000-0003-0346-7960
  • Sánchez Maldonado, José Manuel|||0000-0002-4651-3675
  • ter Horst, Rob|||0000-0003-0576-5873
  • Macauda, Angelica|||0000-0001-9820-5079
  • García Martín, Paloma|||0000-0001-5582-8575
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Landi, Stefano|||0000-0001-8364-6357
  • Clay-Gilmour, Alyssa|||0000-0001-9998-4879
  • Niazi, Yasmeen|||0000-0002-7560-2247
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Rodriguez-Sevilla, Juan Jose|||0000-0002-4741-7925
  • Pérez, Eva María
  • Maffei, Rossana|||0000-0002-3518-2006
  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Giaccherini, Matteo|||0000-0002-0363-6632
  • Cerhan, James R.
  • Marasca, Roberto|||0000-0002-6431-6878
  • Lopez Nevot, Miguel Angel|||0000-0002-3465-6062
  • Chen-Liang, Tzu Hua
  • Thomsen, Hauke|||0000-0001-5951-3116
  • Gámez, Irene
  • Campa, Daniele|||0000-0003-3220-9944
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • de Sanjosé, Silvia
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • García-Álvarez, María Flor
  • Dierssen-Sotos, Trinidad|||0000-0002-6127-0077
  • Jerez, Andrés|||0000-0002-2079-6638
  • Butrym, Aleksandra|||0000-0002-8199-2018
  • Norman, Aaron D.|||0000-0002-4208-2708
  • Luppi, Mario|||0000-0002-0373-1154
  • Slager, Susan|||0000-0002-5173-4712
  • Hemminki, Kari|||0000-0002-2769-3316
  • Li, Yang
  • Berndt, Sonja
  • Casabonne, Delphine
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Puiggros, Anna|||0000-0001-9627-4978
  • Netea, Mihai G.|||0000-0003-2421-6052
  • Försti, Asta|||0000-0002-9857-4728
  • Canzian, Federico|||0000-0002-4261-4583
  • Sainz, Juan|||0000-0002-9355-2423
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of GWAS-identified risk variants to predict disease progression and patient survival remains unexplored. Here, we evaluated whether 41 GWAS-identified risk variants for CLL could influence overall survival (OS) and disease progression, defined as time to first treatment (TTFT) in a cohort of 1039 CLL cases ascertained through the CRuCIAL consortium. Although this is the largest study assessing the effect of GWAS-identified susceptibility variants for CLL on OS, we only found a weak association of ten single nucleotide polymorphisms (SNPs) with OS (p < 0.05) that did not remain significant after correction for multiple testing. In line with these results, polygenic risk scores (PRSs) built with these SNPs in the CRuCIAL cohort showed a modest association with OS and a low capacity to predict patient survival, with an area under the receiver operating characteristic curve (AUROC) of 0.57. Similarly, seven SNPs were associated with TTFT (p < 0.05); however, these did not reach the multiple testing significance threshold, and the meta-analysis with previous published data did not confirm any of the associations. As expected, PRSs built with these SNPs showed reduced accuracy in prediction of disease progression (AUROC = 0.62). These results suggest that susceptibility variants for CLL do not impact overall survival and disease progression in CLL patients.